Ketogenic diet as a metabolic therapy for bipolar disorder: Clinical developments

efficacy of the ketogenic diet as a therapy for intractable epilepsy in children

objective to determine the role of ketogenic diet in the treatment of intractable epilepsy in children. materials & methods sixty six consecutive children (1-16 years old) with intractable epilepsy whose seizure were not neurodegenerative nor febrile in origin were recruited. they received the ketogenic diet and we evaluated its effect on seizure frequency for 3 months. all these children had m...

Ketogenic diet in cancer therapy

A pilot study of the Spanish Ketogenic Mediterranean Diet: an effective therapy for the metabolic syndrome.

The "Spanish Ketogenic Mediterranean Diet" (SKMD) has been shown to promote potential therapeutic properties for the metabolic syndrome. The purpose of this study was to evaluate the potential therapeutic properties under free-living conditions of the SKMD in patients with metabolic syndrome (following the International Diabetes Federation consensus guidelines) over a 12-week period. A prospect...

Lurasidone as a potential therapy for bipolar disorder

Lurasidone is a benzisothiazol derivative and an atypical antipsychotic approved by the US Food and Drug Administration for the acute treatment of adults with schizophrenia (October 2010) and bipolar 1 depression (June 2013). Lurasidone has a strong antagonistic property at the D2, serotonin (5-HT)2A, and 5-HT7 receptors, and partial agonistic property at the 5-HT1A receptor. Lurasidone also ha...

Ketogenic diet therapy for epilepsy during pregnancy: A case series

PURPOSE Evaluation of ketogenic diet (KD) therapies for seizure control during pregnancy when safety and appropriate management become considerations. Until now, no information has been available on seizure reduction and human pregnancy related outcomes in women treated with KD therapies. METHOD We describe two cases of pregnant women with epilepsy treated with KD therapy either as monotherap...